Peter Boström

Which data are available in central registries on bladder cancer patients in the five Nordic countries (2021)

Scandinavian Journal of Urology

Körner Stefanie Korsgaard, Dreyer Thomas, Haug Erik Skaaheim, Jerlström Tomas, Boström Peter J, Gudjonsson Sigurdur, Jensen Jørgen Bjerggaard

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Re: Antonio C. Westphalen, Charles E. McCulloch, Jordan M. Anaokar, et al. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 2020;296:76–84: Can the Positive Predictive Value of Prostate MRI in Correlation with Biopsy Findings be Interpreted Without Diving into Details? (2020)

European Urology Oncology

Ivan Jambor, Ugo G Falagario, Alberto Martini, David Eldred-Evans, Hashim U Ahmed, Peter J Boström; on behalf of the PROMOD Study Group

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures (2020)

Cellular Oncology

Kähkönen TE, Toriseva M, Petruk N, Virta AR, Maher A, Eigeliene N, Kaivola J, Boström P, Koskivuo I, Nees M, Tuomela JM, Ivaska KK, Härkönen PL

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial (2020)

World Journal of Urology

Sell V., Ettala O., Montoya Perez I., Järvinen R., Pekkarinen T., Vaarala M., Seppänen M., Liukkonen T., Marttila T., Aaltomaa S., Kaasinen E., Boström P.J.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment? (2020)

European Urology

van Rhijn BWG, Mertens LS, Mayr R, Bostrom PJ, Real FX, Zwarthoff EC, Boormans JL, Abas C, van Leenders GJLH, Götz S, Hippe K, Bertz S, Neuzillet Y, Sanders J, Broeks A, van der Heijden MS, Jewett MAS, Marquez M, Stoehr R, Zlotta AR, Eckstein M, Soorojebally Y, Roshani H, Burger M, Otto W, Radvanyi F, Sirab N, Pouessel D, Wullich B, van der Kwast TH, Malats N, Hartmann A, Allory Y, Zuiverloon TCM

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men (2020)

Scandinavian Journal of Urology

Knaapila J, Autio V, Jambor I, Ettala O, Verho J, Kiviniemi A, Taimen P, Perez IM, Aronen HJ, Syvänen KT, Boström PJ

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Familial aggregation of testicular cancer among early-onset cancer survivors. A prospective observational cohort data from Finland (2020)

Cancer Epidemiology

Heikki Seikkula, Elli Hirvonen, Antti Kaipia, Peter J Boström, Nea Malila, Janne Pitkäniemi

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results (2020)

European Urology Open Science

Mikael Anttinen, Pietari Mäkelä, Antti Viitala, Pertti Nurminen, Visa Suomi, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review (2020)

Scandinavian Journal of Urology

Boström PJ, Jensen JB, Jerlström T, Arum CJ, Gudjonsson S, Ettala O, Syvänen KT

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type? (2020)

European Urology

Kimmo Kettunen, Peter Boström, Pekka Taimen

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Which data are available in central registries on bladder cancer patients in the five Nordic countries (2021)

Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures (2020)

Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial (2020)

FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment? (2020)

Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men (2020)

Familial aggregation of testicular cancer among early-onset cancer survivors. A prospective observational cohort data from Finland (2020)

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results (2020)

Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review (2020)